FBXO32 and Insulin resistance: The underlying mechanisms may involve multiple pathways, including enhanced skeletal muscle protein degradation, upregulation of atrogin 1 expression, suppression of insulin-like growth factor synthesis, and induction of skeletal muscle insulin resistance [56,57].